December 15, 2010 – Definiens and aycan have formed a partnership to complete the first joint project to quantify and analyze lung tumors.
Under the partnership, Definiens has combined its LungExpert with aycan’s OsiriX PRO to create a workstation that quantifies lung tumors according to RECIST and WHO guidelines and also by their volume. This new integrated solution enables efficient analysis of lesions, including automated quantification of lung tumors.
The new workstation is expected to be available in early 2011.
For more information: www.aycan.com, www.definiens.com
Related Content
News | Stroke
March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...
March 11, 2026 
News | Radiation Oncology
March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...
March 05, 2026 
News | Radiation Therapy
Feb. 26, 2026 — GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, has ...
February 27, 2026 
News | FDA
Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...
February 26, 2026 
News | FDA
Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...
February 03, 2026 
Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...
January 23, 2026 
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles
Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...
October 31, 2025 
News | X-Ray
Sept. 8, 2025 — A new clinical case study, presented by Qure.ai and Hacettepe University, Turkey, at the IASLC World ...
September 10, 2025 
Feature | Artificial Intelligence
Brain metastases are 10 times more common than primary brain tumors, occurring in 10 to 20% of adult patients with ...
September 04, 2025 
News | Ultrasound Imaging
Aug. 8, 2025 — Memorial Hermann-Texas Medical Center announced it will begin using a new FDA-approved ultrasound device ...
August 11, 2025 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now